| Followers | 27 |
| Posts | 20651 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Monday, April 20, 2026 4:19:10 PM
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
April 20, 2026 4:05 PM
Business Wire
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial and operating results after the market close on Thursday, May 7, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial 1-800-343-5172 or 1-203-518-9856 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260420078369/en/
Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
Original: Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
Recent MRVI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 10:59:58 PM
- Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference • Business Wire • 05/18/2026 08:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:30:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 08:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:05:56 PM
- Maravai LifeSciences Reports First Quarter 2026 Financial Results • Business Wire • 05/07/2026 08:01:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:29:27 PM
- Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 • Business Wire • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:16:39 PM
- Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 02/25/2026 09:01:00 PM
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 • Business Wire • 02/09/2026 10:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 10:28:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/23/2025 08:00:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/19/2025 09:38:53 PM
- Maravai LifeSciences Announces November 2025 Investor Conference Schedule • Business Wire • 11/10/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:21:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 09:03:24 PM
- Maravai LifeSciences Reports Third Quarter 2025 Financial Results • Business Wire • 11/06/2025 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 08:23:34 PM
- Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 • Business Wire • 10/22/2025 08:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/17/2025 10:13:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 09:02:50 PM
